Thoracic Oncologist Highlights Recent Pembrolizumab Data in NSCLC
Published: Monday, Nov 19, 2018
Tracey L. Evans, MD
Pembrolizumab (Keytruda) has emerged as an effective frontline treatment option for select patients with metastatic non–small cell lung cancer (NSCLC), explained Tracey L. Evans, MD.
... to read the full story